trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Pan L et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. 2007 Cancer pmid:17330857
Xu J et al. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. 2010 Breast Cancer Res. Treat. pmid:19466541
Motevalli A et al. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. 2014 Breast Cancer Res. Treat. pmid:24807106
Domingo-Domènech J et al. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells. 2008 Breast Cancer Res. Treat. pmid:18064564
Huang KT et al. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer. 2011 Breast Cancer Res. Treat. pmid:21755341
Pryzbylkowski P et al. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. 2008 Breast Cancer Res. Treat. pmid:17891453
Auer D et al. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. 2009 Breast Cancer Res. Treat. pmid:18618240
Kim SH et al. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. 2010 Breast Cancer Res. pmid:20388208
Zych J et al. The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. 2013 Braz. J. Med. Biol. Res. pmid:23797495
Sawa H et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. 2002 Brain Tumor Pathol pmid:12622137
Sawa H et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. 2001 Brain Tumor Pathol pmid:11908866
Sakharkar AJ et al. A role for histone acetylation mechanisms in adolescent alcohol exposure-induced deficits in hippocampal brain-derived neurotrophic factor expression and neurogenesis markers in adulthood. 2016 Brain Struct Funct pmid:26941165
Sharifulina SA et al. Epigenetic regulation of death of crayfish glial cells but not neurons induced by photodynamic impact. 2014 Brain Res. Bull. pmid:24502940
Niu F et al. Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. 2009 Brain Res. Bull. pmid:19103266
Lin YC et al. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. 2008 Brain Res. pmid:18950606
Suzuki-Mizushima Y et al. Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. 2002 Brain Res. pmid:12270499
Sano M and Kitajima S Inhibition of the nerve growth factor-induced outgrowth of neurites by trichostatin A requires protein synthesis de novo in PC12D cells. 1996 Brain Res. pmid:9117395
Wei L et al. Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization. 2016 Brain Res. pmid:27312092
Hou X et al. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord. 2017 Brain Res. pmid:28559159
Li KK et al. MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). 2013 Brain Pathol. pmid:23227829
Li KK et al. MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. 2013 Brain Pathol. pmid:23252729
Gaub P et al. The histone acetyltransferase p300 promotes intrinsic axonal regeneration. 2011 Brain pmid:21705428
Xin C et al. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. 2007 Br. J. Pharmacol. pmid:17325654
Matsushita Y et al. HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. 2013 Br. J. Pharmacol. pmid:24032674
Ishihara K et al. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. 2004 Br. J. Pharmacol. pmid:15210580
Chen CZ et al. The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. 2009 Br. J. Pharmacol. pmid:19785660
Hoshimoto A et al. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. 2002 Br. J. Pharmacol. pmid:12010777
Kiefer J et al. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. 2006 Br. J. Nutr. pmid:17092367
Amin HM et al. Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). 2001 Br. J. Haematol. pmid:11703323
Vinatzer U et al. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. 2001 Br. J. Haematol. pmid:11552981
Welch MD et al. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia. 2013 Br. J. Haematol. pmid:23772794
Kitamura K et al. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. 2000 Br. J. Haematol. pmid:10792271
Yamamura K et al. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis. 2006 Br. J. Haematol. pmid:16939493
Li X et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. 2010 Br. J. Haematol. pmid:19807731
Yasukawa K et al. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts. 2007 Br. J. Dermatol. pmid:17711521
Truong M et al. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. 2012 Br. J. Cancer pmid:22596233
Meng F et al. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer. 2013 Br. J. Cancer pmid:23370212
Zaman MS et al. The functional significance of microRNA-145 in prostate cancer. 2010 Br. J. Cancer pmid:20588276
Ridolfi E et al. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. 2008 Br. J. Cancer pmid:18941460
El-Khoury V et al. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. 2007 Br. J. Cancer pmid:17667922
Yamada N et al. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. 2009 Br. J. Cancer pmid:19127263
Chang J et al. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide. 2012 Br. J. Cancer pmid:22158273
Frame FM et al. HDAC inhibitor confers radiosensitivity to prostate stem-like cells. 2013 Br. J. Cancer pmid:24220693
Moreaux J et al. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors. 2013 Br. J. Cancer pmid:23868005
Carén H et al. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. 2007 Br. J. Cancer pmid:17940511
Dote H et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. 2005 Br. J. Cancer pmid:15770214
Huynh NC et al. Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells. 2017 Bone pmid:27871909
Bieluszewski T et al. AtEAF1 is a potential platform protein for Arabidopsis NuA4 acetyltransferase complex. 2015 BMC Plant Biol. pmid:25849764
Yang F et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. 2010 BMC Plant Biol. pmid:20718950
Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. 2010 BMC Neurosci pmid:20137068